Novo Nordisk's pricing techniques during the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who may have accused the company of cost gouging, stating the stark distinction among U.S. charges and those in Europe and copyright. Scientific studies of Rybelsus and copyri